Yi Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Luo has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anzhi Chen
School of Computer Science and Technology, North China University of Technology Beijing China
1 shared publicationEriko Tanabe
Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634‑8521, Japan
1 shared publication- Hiroki Kuniyasu
Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634‑8521, Japan
1 shared publication - Hitoshi Ohmori
Department of Molecular Pathology, Nara Medical University, Kashihara, Japan
1 shared publication Kaicheng U
Department of Computational Biology College of Agriculture and Life Sciences, Cornell University Ithaca New York USA
1 shared publicationKiyomu Fujii
Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634‑8521, Japan
1 shared publication
Latest Publications
- Open Access
- 18 November 2024
- Published by Wiley in Thoracic Cancer
- Vol. 16 (1)
Optical sensor for fast and accurate lung cancer detection with tissue autofluorescence and diffuse reflectance spectroscopy
Background: Cancer is a severe threat to human health, and surgery is a major method of cancer treatment. This study aimed to develop an optical sensor for fast cancer tissue.Methods: The tissue autofluorescence spectrum and diffuse reflectance spectrum were obtained by using a laboratory‐developed optical sensor system. A total of 151 lung tissue samples were used in this ex vivo study.Results: Experimental results demonstrate that tissue autofluorescence spectroscopy with a 365‐nm excitation has better performance than diffuse reflectance spectroscopy, and 63 of 64 test samples (98.4% accuracy) were correctly classified with tissue autofluorescence spectroscopy and our developed data analysis method.Conclusions: Our promising ex vivo study results show that the developed optical sensor system has great promise for future clinical translation for intraoperative lung cancer detection and other applications.
- 18 November 2024
- Published by Wiley in Thoracic Cancer
- Vol. 16 (1)
Open AccessOptical sensor for fast and accurate lung cancer detection with tissue autofluorescence and diffuse reflectance spectroscopy
Background: Cancer is a severe threat to human health, and surgery is a major method of cancer treatment. This study aimed to develop an optical sensor for fast cancer tissue.Methods: The tissue autofluorescence spectrum and diffuse reflectance spectrum were obtained by using a laboratory‐developed optical sensor system. A total of 151 lung tissue samples were used in this ex vivo study.Results: Experimental results demonstrate that tissue autofluorescence spectroscopy with a 365‐nm excitation has better performance than diffuse reflectance spectroscopy, and 63 of 64 test samples (98.4% accuracy) were correctly classified with tissue autofluorescence spectroscopy and our developed data analysis method.Conclusions: Our promising ex vivo study results show that the developed optical sensor system has great promise for future clinical translation for intraoperative lung cancer detection and other applications.
- Open Access
- 17 May 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 681-686
Fatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines
The present study investigated the effects of two major dietary fatty acid components, linoleic acid (LA) and elaidic acid (EA), on the antitumor effects of 5-fluorouracil (5‑FU) in the LL2, CT26 and CMT93 mouse cancer cell lines. Concurrent treatment with LA and 5‑FU elicited a decreased cell viability compared with treatment with 5‑FU alone. In addition, increased inhibition of growth was observed following concurrent treatment with EA and 5‑FU. Sequential treatment of LA followed by 5‑FU abrogated the anticancer effects of 5‑FU, and treatment with EA followed by 5‑FU increased cancer cell growth in addition to abrogating the anticancer effects of 5‑FU. The expression of the stem cell markers CD133 and nucleostemin (NS) increased in all three cell lines treated concurrently with 5‑FU and either LA or EA when compared with cells treated with 5‑FU alone. Aldehyde dehydrogenase activity in the cancer stem cells (CSCs), in response to concurrent treatment with 5‑FU and either LA or EA, was increased compared with 5‑FU treatment alone. 5‑FU inhibited the growth of CT26 tumors, but co‑treatment with either LA or EA abrogated this effect. NS‑positive CSCs were more abundant in CT26 tumors treated with 5‑FU and either LA or EA compared with those treated with 5‑FU alone. The results of the present study suggested that, rather than altering the sensitivity of cancer cells to 5‑FU, LA and EA may promote the survival of CSCs. The results indicated that dietary composition during chemotherapy is an important issue.
- 17 May 2017
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (1) , 681-686
Open AccessFatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines
The present study investigated the effects of two major dietary fatty acid components, linoleic acid (LA) and elaidic acid (EA), on the antitumor effects of 5-fluorouracil (5‑FU) in the LL2, CT26 and CMT93 mouse cancer cell lines. Concurrent treatment with LA and 5‑FU elicited a decreased cell viability compared with treatment with 5‑FU alone. In addition, increased inhibition of growth was observed following concurrent treatment with EA and 5‑FU. Sequential treatment of LA followed by 5‑FU abrogated the anticancer effects of 5‑FU, and treatment with EA followed by 5‑FU increased cancer cell growth in addition to abrogating the anticancer effects of 5‑FU. The expression of the stem cell markers CD133 and nucleostemin (NS) increased in all three cell lines treated concurrently with 5‑FU and either LA or EA when compared with cells treated with 5‑FU alone. Aldehyde dehydrogenase activity in the cancer stem cells (CSCs), in response to concurrent treatment with 5‑FU and either LA or EA, was increased compared with 5‑FU treatment alone. 5‑FU inhibited the growth of CT26 tumors, but co‑treatment with either LA or EA abrogated this effect. NS‑positive CSCs were more abundant in CT26 tumors treated with 5‑FU and either LA or EA compared with those treated with 5‑FU alone. The results of the present study suggested that, rather than altering the sensitivity of cancer cells to 5‑FU, LA and EA may promote the survival of CSCs. The results indicated that dietary composition during chemotherapy is an important issue.